Scorpio Tankers Announces Repurchase Of 222,396 Common Shares At $41.27/Share
Today, the Company purchased 222,396 of its common shares in the open market at an average price of $41.27 per share as part of the Company's securities repurchase program.
CTI BioPharma Announces Presentation of New Anemia Benefit Data from Pacritinib Program at the Society of Hematologic Oncology (SOHO) Tenth Annual Meeting
CTI BioPharma Corp. (NASDAQ:CTIC) today announced two poster presentations from the Company's pacritinib program at the Society of Hematologic Oncology (SOHO) Tenth Annual Meeting, to be held in Houston,
DBV Technologies Provides Clinical Update on VITESSE Phase 3 Trial, FDA Places Partial Clinical Hold On Co.’s VITESSE Phase 3 Clinical Study
DBV Technologies (GREY:DBVTF), a clinical-stage biopharmaceutical company, today announced that it received feedback from the U.S. Food and Drug Administration (FDA) in the form of a partial clinical hold on its VITESSE
